Curiox Biosystems

큐리옥스바이오시스템즈(주) · KOSDAQ · 445680 · Industry: Manufacture of medical and dental instruments and supplies

Key metrics

Earnings

Revenue, Q3 2026₩1.5bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ+26.9% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY+7.8% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026-₩3.9bn As of Sep 30, 2026 Source 1 ↗
Operating income QoQ+12.2% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoY-46.1% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩0 As of Nov 19, 2026
Buyback decided, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩0 As of Nov 19, 2026
Rights offering new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Supply contracts

Supply contracts, last 12 months₩0 As of Nov 19, 2026
Supply contracts vs prior-year revenue0.0% As of Nov 19, 2026
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months10 As of Nov 19, 2026
DART filings, previous 3 months8 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market buys, last 12 months (amount)₩0 As of Nov 19, 2026
Open-market sells, last 12 months (shares)113,678 shares As of Aug 12, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗
Open-market sells, last 12 months (amount)₩5.2bn As of Aug 12, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗
Net open-market buying, last 12 months (shares)-113,678 shares As of Aug 12, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗
Insiders who bought, last 12 months0 As of Nov 19, 2026

Insider transactions (last 12 months)

Open-market buys: 0 shares (₩0). Open-market sells: 113,678 shares (₩5.2bn). Net open-market buying: -113,678 shares. Insiders who bought: 0.

Trade dateInsider (role)TypeSharesPriceAmount
Nov 5, 2026Jung Hong-tae (Registered director)Other (Stock option exercise)+6,396 shares₩3,091₩20m
Nov 5, 2026Noh Hui-jun (Non-registered officer)Other (Stock option exercise)+900 shares₩4,416₩4m
Nov 5, 2026Noh Hui-jun (Non-registered officer)Other (Stock option exercise)+4,500 shares₩22,711₩102m
Nov 3, 2026Kim Nam-yong (Registered director, 10%+ shareholder)Other (After-hours sell)-570,000 shares₩45,942₩26.2bn
Aug 12, 2026Kim Nam-yong (Registered director, 10%+ shareholder)Open-market sell-105,500 shares₩42,723₩4.5bn
Aug 3, 2026Park Yeong-ho (Non-registered officer)Other (Stock option exercise)+3,000 shares₩4,416₩13m
Apr 9, 2026Jung Hong-tae (Registered director)Open-market sell-578 shares₩82,919₩48m
Apr 8, 2026Jung Hong-tae (Registered director)Open-market sell-4,400 shares₩80,987₩356m
Apr 7, 2026Jung Hong-tae (Registered director)Open-market sell-2,200 shares₩78,326₩172m
Apr 3, 2026Park Yeong-ho (Non-registered officer)Other (Stock option exercise)+9,096 shares₩7,729₩70m
Apr 3, 2026Park Seong-cheol (Non-registered officer)Other (Stock option exercise)+16,000 shares₩19,482₩312m
Apr 3, 2026Jung Hong-tae (Registered director)Other (Stock option exercise)+30,000 shares₩3,197₩96m
Apr 3, 2026Noh Hui-jun (Non-registered officer)Other (Stock option exercise)+1,164 shares₩4,416₩5m
Jan 7, 2026Noh Hui-jun (Non-registered officer)Open-market sell-1,000 shares₩115,625₩116m
Nov 25, 2025Noh Hui-jun (Non-registered officer)Other (Stock option exercise)+1,512 shares₩4,416₩7m

Annual financials

YearRevenueOperating income
2025₩5.2bn-₩12.3bn
2024₩4.6bn-₩13.4bn
2023₩6.8bn-₩10.6bn

Filing timeline